Comments
Loading...
Viracta Therapeutics (NASDAQ:VIRX) Stock, Earnings Estimates, EPS, And Revenue
Viracta Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 6
EPS Estimate
$-0.190
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Viracta Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Viracta Therapeutics (VIRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-13 | $-0.27 | $-0.24 | -12.5 % |
| Jun 2024 | 2024-08-14 | $-0.25 | $-0.37 | 32.4 % |
| Mar 2024 | 2024-05-09 | $-0.23 | $-0.29 | 20.7 % |
| Dec 2023 | 2024-03-07 | $-0.35 | $-0.31 | -12.9 % |
Viracta Therapeutics (VIRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Viracta Therapeutics (NASDAQ:VIRX) reporting earnings?
Viracta Therapeutics (VIRX) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Viracta Therapeutics (NASDAQ:VIRX)?
The Actual EPS was $-0.27, which missed the estimate of $-0.24.
What were Viracta Therapeutics’s (NASDAQ:VIRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.